Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POLish Bifurcation Optimal Treatment Strategy (POLBOS 3) Randomized Study

NCT03548272 is registered in ClinicalTrials.gov with Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland as lead sponsor.

NCT NCT03548272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03548272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POLish Bifurcation Optimal Treatment Strategy (POLBOS 3) Randomized Study
Lead sponsor
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Phase
Phase 4
Overall status
Unknown status
Start date
June 12, 2018
Completion date
June 30, 2020
Enrollment
518 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease